Acorda Therapeutics (26) | Human Resources (12)
Browse by Subcategory
Recent Contracts
-
Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D
(Filed With SEC on March 18, 2022)
-
Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella
(Filed With SEC on March 18, 2022)
-
Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D
(Filed With SEC on March 18, 2022)
-
Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan
(Filed With SEC on May 12, 2021)
-
Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer
(Filed With SEC on May 12, 2021)
-
Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021
(Filed With SEC on May 12, 2021)
-
Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser
(Filed With SEC on March 18, 2022)
-
Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff
(Filed With SEC on March 18, 2022)
-
Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem
(Filed With SEC on September 9, 2021)
-
Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman
(Filed With SEC on February 28, 2020)
-
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence
(Filed With SEC on November 7, 2019)
-
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman
(Filed With SEC on November 7, 2019)